Ertugliflozin Pidolate

Overview

Ertugliflozin Pidolate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL5315054).

API suppliers (6)

Suppliers of Ertugliflozin Pidolate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• MSN Laboratories Private LimitedIndia2 active DMF GMP on record
• HIKAL LTDPakistan1 active DMF
• BIOPHORE INDIA PHARMACEUTICALS PVT LTD1 active DMF
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
• HONOUR LAB LTDIndia1 active DMF GMP on record
• Shandong Loncom Pharmaceutical Co.,ltd.China1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (2 approved US products), the latest listed US patent on Ertugliflozin Pidolate expires 19 Dec 2031. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

(1S,2S,3S,4R,5S)-5-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol;(2S)-5-oxopyrrolidine-2-carboxylic acid

Canonical SMILES

CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@@]34[C@@H]([C@H]([C@@H]([C@@](O3)(CO4)CO)O)O)O)Cl.C1CC(=O)N[C@@H]1C(=O)O

InChIKey

YHIUPZFKHZTLSH-LXYIGGQGSA-N